Your browser doesn't support javascript.
loading
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy.
Kim, R; Kwon, M; An, M; Kim, S T; Smith, S A; Loembé, A B; Mortimer, P G S; Armenia, J; Lukashchuk, N; Shah, N; Dean, E; Park, W-Y; Lee, J.
Affiliation
  • Kim R; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kwon M; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea.
  • An M; Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim ST; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Smith SA; Oncology R&D, AstraZeneca, Cambridge, UK.
  • Loembé AB; Oncology R&D, AstraZeneca, Cambridge, UK.
  • Mortimer PGS; Oncology R&D, AstraZeneca, Cambridge, UK.
  • Armenia J; Oncology R&D, AstraZeneca, Cambridge, UK.
  • Lukashchuk N; Oncology R&D, AstraZeneca, Cambridge, UK.
  • Shah N; Oncology R&D, AstraZeneca, Cambridge, UK.
  • Dean E; Oncology R&D, AstraZeneca, Cambridge, UK.
  • Park WY; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea; Geninus Inc., Seoul, Korea.
  • Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon, Korea. Electronic address: jyunlee@skku.edu.
Ann Oncol ; 33(2): 193-203, 2022 02.
Article de En | MEDLINE | ID: mdl-34710570

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Mélanome Limites: Humans Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Mélanome Limites: Humans Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article